Feiba Kit
Product Images NDC 64193-425

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Feiba (NDC 64193-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Feiba 01)

An illustration showing the opened pages of a booklet or manual, with one page displaying a detailed drawing of a medical device or component, likely related to the FEIBA kit.*

FDA Label Image

Figure B (Feiba 02)

An instructional diagram showing two vials, one larger and one smaller, with arrows indicating the addition of the liquid from the larger vial into the smaller vial for mixing or preparation. The smaller vial has a gray cap with a protective flap being lifted.*

FDA Label Image

Figure C (Feiba 03)

An instructional diagram showing two vials with arrows indicating to lift or remove a cap from the larger vial's top. The image likely illustrates a step in preparing or assembling components of the FEIBA kit, an anti-inhibitor coagulant complex.*

FDA Label Image

Figure D (Feiba 04)

An instructional diagram showing the assembly process of two components: a vial and an attached device with a cap. The image illustrates aligning and connecting the device to the vial, indicated by a downward arrow, likely related to the preparation or administration of the FEIBA kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure E (Feiba 05)

An instructional illustration showing how to prepare the FEIBA kit, an anti-inhibitor coagulant complex. The diagram depicts a two-vial system with arrows indicating the sequence for drawing fluid from one vial into a syringe before transferring it to the second vial. The image emphasizes the correct handling steps for mixing or reconstituting the medication.*

FDA Label Image

Figure F (Feiba 06)

An illustration showing a medical kit component for FEIBA, an anti-inhibitor coagulant complex. The image depicts a liquid vial connected to a syringe with a plunger and a scale for measuring dosage, indicating preparation for administration characteristic of the dosage form labeled as a kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Principal Display Panel (Kit Carton)

FEIBA Anti-Inhibitor Coagulant Complex kit, nanofiltered and vapor heated, 20 mL dried size. Packaging includes the Shire logo and mentions the inclusion of BAXJECT II Hi-Flow needleless transfer device. The label states it is for intravenous use after reconstitution and contains no preservatives. The product is labeled with NDC 64193-424-02 and is distributed by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

FEIBA anti-inhibitor coagulant complex 20 mL dried kit packaging label by Takeda Pharmaceuticals America, Inc. The label specifies nanofiltered and vapor heated product, intended for intravenous use after reconstitution with 20 mL SWFI. It instructs to store between 2°C to 25°C and use within 3 hours post-reconstitution. The label includes dosage and administration references to the package insert and displays the Shire logo.*

FDA Label Image

Principal Display Panel (Kit Carton)

FEIBA anti-inhibitor coagulant complex single-dose vial kit packaging label. The label indicates the product is nanofiltered and vapor heated. It includes a BAXJECT II Hi-Flow needleless transfer device. The label states it is for intravenous use after reconstitution, with storage and usage instructions. The labeler is Takeda Pharmaceuticals America, Inc., formerly Shire, and the NDC is 64193-425-02.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

FEIBA anti-inhibitor coagulant complex kit label for intravenous use after reconstitution. The label indicates a 50 mL dried size, is nanofiltered and vapor heated, contains no preservative, and includes storage and reconstitution instructions. The label specifies it is Rx only and includes barcodes and lot or expiration date placeholders. The labeler is Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Principal Display Panel (Kit Carton)

FEIBA anti-inhibitor coagulant complex kit packaging label from Takeda Pharmaceuticals America, Inc. It includes a single-dose vial, nanofiltered and vapor heated. The label shows storage conditions, usage instructions after reconstitution, and warnings about potential hazards. The package contains FEIBA, 10 mL sterile water for injection, a BAXJECT II Hi-Flow needleless transfer device, and a package insert.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

FEIBA Anti-Inhibitor Coagulant Complex single-dose vial label with nanofiltered and vapor heated processing. The label states for intravenous use after reconstitution, includes storage temperature (36°F to 77°F), and instructions to use 10 mL sterile water for injection for reconstitution. Labeler is Takeda Pharmaceuticals America, Inc., with branding from Shire. Contains various barcodes and space for lot number, expiration date, and units.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.